http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200702377-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2006-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200702377-A1
titleOfInvention DERIVATIVES OF BENZOTRIAZOLE AS ANTAGONISTS OF CANNABINOID RECEPTOR
abstract This invention relates to the group of benzotriazole derivatives below, which are effective modulators of the cannabinoid CB receptor (known as antagonists or inverse agonists), effective in the treatment of obesity, mental and neurological disorders, as well as other diseases in which neuronal transmission of cannabinoid-CB is involved (Current Opinion in Drug Discovery & Development 2004 7 (4): 498-506), their pharmaceutically acceptable acid addition salts and stereoisomeric forms, where R is hydrogen, halogen, trifluoromethyl , C1-6alkyl, C1-6alkyloxy or C1-6alkyloxycarbonyl-; R 1 is hydrogen, phenyl, Cycloalkyl or C 1-6 alkyl optionally substituted with Ar; R 1 is hydrogen, hydroxyl or C 1-6 alkyl; Ar is phenyl or phenyl substituted with up to three substituents; and Het is a monocyclic 5- or 6-membered partially saturated or aromatic heterocycle selected from furanyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl, pyridinyl pyrimidinyl , pyridazinyl, 2H-pyranyl or 4H-pyranyl, wherein said heterocycle is optionally substituted with C1-6alkyl.
priorityDate 2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457633375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457629025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457522789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 27.